First-line pemetrexed plus cisplatin followed by maintenance pemetrexed versus carboplatin-paclitaxel plus bevacizumab followed by maintenance bevacizumab (ERACLE) in advanced nonsquamous NSCLC: A quality-of-life-oriented, multicenter randomized phase III trial of the GOIM (Gruppo Oncologico Italia Meridionale).
Domenico Galetta
No relevant relationships to disclose
Salvatore Pisconti
No relevant relationships to disclose
Saverio Cinieri
No relevant relationships to disclose
Vittorio Gebbia
No relevant relationships to disclose
Alessandro Morabito
No relevant relationships to disclose
Nicolo Borsellino
No relevant relationships to disclose
Evaristo Maiello
No relevant relationships to disclose
Antonio Febbraro
No relevant relationships to disclose
Annamaria Catino
No relevant relationships to disclose
Pietro Rizzo
No relevant relationships to disclose
Michele Montrone
No relevant relationships to disclose
Giovanni Simone
No relevant relationships to disclose
Vito Lorusso
No relevant relationships to disclose
Daniele Rizzi
No relevant relationships to disclose
Giovanni L. Pappagallo
No relevant relationships to disclose
Giuseppe Colucci
No relevant relationships to disclose